USAXRTX▼
XORTX Director Anthony Giovinazzo Steps Down from Board
XORTX Therapeutics announced that Anthony Giovinazzo is stepping down from its board of directors for personal reasons and to pursue other interests. Dr. Allen Davidoff, co-CEO of XORTX, expressed appreciation for Giovinazzo's efforts as chairman of the board over the past several years, highlighting his leadership and ethical standards. XORTX is a late-stage clinical pharmaceutical company focused on developing therapies for gout and progressive kidney disease.